Transcat, Inc. (NASDAQ:TRNS) Receives $130.25 Average PT from Brokerages

Shares of Transcat, Inc. (NASDAQ:TRNSGet Free Report) have been assigned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $130.25.

A number of equities research analysts have recently issued reports on the stock. Northland Securities lowered their price target on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a report on Wednesday, October 30th. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a report on Tuesday, October 29th. Craig Hallum upped their price target on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. Oppenheimer reissued an “outperform” rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. Finally, HC Wainwright restated a “buy” rating and issued a $156.00 target price on shares of Transcat in a research note on Tuesday, October 29th.

Read Our Latest Stock Analysis on TRNS

Transcat Price Performance

Shares of TRNS stock opened at $108.26 on Friday. The stock has a market capitalization of $995.88 million, a price-to-earnings ratio of 54.68 and a beta of 0.71. The company’s fifty day simple moving average is $105.72 and its two-hundred day simple moving average is $117.39. Transcat has a 1 year low of $94.29 and a 1 year high of $147.12.

Transcat (NASDAQ:TRNSGet Free Report) last released its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.36%. The company had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. During the same quarter in the previous year, the firm posted $0.41 earnings per share. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. Equities research analysts anticipate that Transcat will post 1.76 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Arizona State Retirement System boosted its holdings in shares of Transcat by 5.3% in the 2nd quarter. Arizona State Retirement System now owns 2,555 shares of the scientific and technical instruments company’s stock worth $306,000 after purchasing an additional 129 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its stake in Transcat by 1.6% in the second quarter. Oppenheimer Asset Management Inc. now owns 10,562 shares of the scientific and technical instruments company’s stock worth $1,264,000 after buying an additional 171 shares in the last quarter. Essex Investment Management Co. LLC grew its position in Transcat by 0.4% during the third quarter. Essex Investment Management Co. LLC now owns 43,444 shares of the scientific and technical instruments company’s stock valued at $5,247,000 after acquiring an additional 171 shares during the last quarter. US Bancorp DE grew its position in Transcat by 15.6% during the third quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock valued at $187,000 after acquiring an additional 209 shares during the last quarter. Finally, Ellsworth Advisors LLC raised its stake in shares of Transcat by 4.4% during the third quarter. Ellsworth Advisors LLC now owns 5,041 shares of the scientific and technical instruments company’s stock worth $609,000 after acquiring an additional 213 shares in the last quarter. Institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

(Get Free Report

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Featured Stories

Analyst Recommendations for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.